ORBIS Day announced at 25th anniversary

Article

The 1st of March was declared "ORBIS Day" in New York City, USA, by Mayor Michael R. Bloomberg.

The 1st of March was declared "ORBIS Day" in New York City, USA, by Mayor Michael R. Bloomberg at the celebration of ORBIS's 25th anniversary at the United Nations.

ORBIS International, best known for the world's only Flying Eye Hospital, is dedicated to saving sight across the world and more than 80 heads of state and the past three secretaries general of the UN gathered to recognize its achievements.

To recognize the 28 million people, worldwide, who are needlessly blind, the tower lights of the Empire State building were turned off for 28 minutes and, when re-lit, the building was lit in blue and white in honour of ORBIS.

A call for global action was launched with a $10 million gift from A.L. Ueltschi, chairman of FlightSafety International and chairman of the ORBIS International board of directors; the largest gift ever received by the organisation.

Numerous companies have also pledged money, and it is hoped that the overall fund will total around $100 million.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.